AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-80
SponsorNational Heart Centre Singapore
About this trial
The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.
Eligibility criteria
Qualifiers
Age ≥21 years old
Signed informed consent
Clinically indicated for evaluation by CTCA
Disqualifiers
Individuals unable to provide informed consent
Known complex congenital heart disease
Planned invasive angiography for reasons other than CAD
Non-cardiac illness with life expectancy < 2 years
Trial design
Treatments tested in this trial
- CTCA
Treatment groups
8,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
National Heart Centre Singapore
Lead sponsor
Agency for Science, Technology and Research
Collaborator
Source ClinicalTrials.gov